Wharf Hotels Management Limited
Emanating the spirit of discovery, Wharf Hotels Management Limited trading as Wharf Hotels, a wholly owned subsidiary of The Wharf (Holdings) Ltd, is based in Hong Kong. It currently operates 14 owned or managed luxury and premium brands, Niccolo and Marco Polo Hotels in Hong Kong, China and the Philippines. Niccolo Hotels was added to the groupÍs portfolio in 2015 in Chengdu as the new luxury collection with 4 new Niccolo Hotels currently under development in Chongqing, Hong Kong, Changsha and Suzhou, bringing the group to 18 hotels in total.
Niccolo, named after the father of Marco Polo, comprises a collection of contemporary urban chic hotels with the most desirable, highly prized addresses. At heart, as discoverers and re-discoverers of luxury experiences, styles and tastes, the hotels are modern sophisticated spaces, where the timeless pleasures of impeccable hospitality from another golden era in travel are valued. Underpinning everything is the desire to make life effortlessly luxurious.
Marco Polo Hotels maintains its long-standing ethos of discovery, creating unique guest experiences and drawing on the key philosophies of its namesake, Marco Polo: an adventurer, a traveller, an entrepreneur and a connoisseur of culture - just as Marco PoloÍs modern travellers are today.
The legendary spirit for travel, exploring and sharing experiences is the embodiment of Niccolo and Marco Polo Hotels and can be found in each of its vibrant cities.
At Wharf Hotels, we take pride in providing our associates and colleagues with a career in which they can excel.
For careers with Wharf Hotels, Niccolo and Marco Polo Hotels, please visit wharfhotels.com.
For more information about Wharf Hotels, please visit wharfhotels.com.
- Company Name:Wharf Hotels
(View Trends)
-
Headquarters: (View Map)Tsim Sha Tsui, Kowloon, Hong Kong
-
Hospitality
-
5,000 - 10,000 employees
- 19873787 Global Rank
- 1136384 Malaysia
-
Search100.00%
-
Direct0.00%
-
Display0.00%
-
Mail0.00%
-
Referrals0.00%
-
Social0.00%
- United States 100.0%
- Biotechnology and Pharmaceuticals